In that work, Gmnn over-expression promoted premature Topo IIα release from chromatin and increased the resistance of HME and breast cancer cells to Topo IIα inhibitors such as etoposide, which trap the transient Topo IIα reaction intermediate on chromatin to prevent DNA religation and promote cell death. This evidence concerns the gene GMNN and breast carcinoma.